- Sep 18, 2020 Roche Announces Results of EMPACTA Study for Chugai’s Actemra for the Treatment of COVID-19
- Sep 10, 2020 New Data of Chugai’s Enspryng (Satralizumab) on Risk and Severity of Relapse in Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Sep 10, 2020 Chugai and Takeda to Join a Clinical Collaboration for Global Phase III Studies for the Combination Therapy with Multiple Tumor Types in Japan
- Sep 09, 2020 Chugai and NTT DATA Complete Demonstration of AI-based Clinical Trial Efficiency Solution.
- Sep 07, 2020 Online Disease Awareness Activity for Better Understanding Breast Cancer at TOKYO GIRLS COLLECTION